Whole-body and intracellular arginine metabolism in hypertension: role of disease severity and sex.
V N Hüttl, Nep Deutz, R A Wierzchowska-McNew...
https://pubmed.ncbi.nlm.nih.gov/42149813/Actively Recruiting
Led by Texas A&M University · Updated on 2025-11-25
100
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying how different types of protein, specifically plant-based versus animal-based proteins, affect muscle-building responses in older adults, including those with sarcopenia and chronic obstructive pulmonary disease COPD. The study aims to understand how essential and non-essential amino acids influence these responses to help develop better nutritional strategies to prevent and treat muscle loss in aging populations. Participants will consume one of four liquid nutritional supplements during study visits whey protein animal-based, soy protein plant-based, pea protein plant-based, or a placebo of water. These supplements are given as sip feeds every 20 minutes over a 5-hour period. The study includes a screening visit and four study days, with participants having the option to add sugar-free vanilla, caramel, or chocolate syrup to their drinks. Participants will visit the research center fasting, undergo body composition and muscle function tests, and provide blood samples before and after feeding to measure protein and amino acid synthesis using stable isotope tracers. Vital signs and physical performance tests like the Six-Minute Walk Test are conducted. The study tracks metabolic responses and muscle function over about four weeks, with all data securely stored for analysis.
CONDITIONS
Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein
M
Marielle Engelen, PhD
S
Savanah Knezek, BS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Texas A&M University
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Plant‑based protein isolate | Whey protein isolate |
|---|---|---|
| What it is | Investigation of plant‑based protein isolate (soy or pea) nutritional supplement | Comparison using whey protein isolate (animal‑based) supplement |
| Role in the trial | Serves as one of the test protein conditions in crossover design | Serves as the control/comparator protein condition in crossover design |
| Purpose being tested | Assess metabolic (anabolic) response to plant‑based protein in older adults with or without sarcopenia or COPD | Assess metabolic (anabolic) response to whey protein in older adults with or without sarcopenia or COPD |
| How it is administered | Given as plant‑based protein powder feeding during prandial metabolic phenotyping | Given as whey protein isolate powder feeding during prandial metabolic phenotyping |
| Prevailing evidence in older adults | Evidence suggests plant‑based protein may produce similar anabolic effects to animal protein but conclusions are limited by few studies and wide confidence intervals | Animal‑based (whey) protein generally yields small advantages in muscle mass over non‑soy plant protein, particularly in younger adults, but differences are smaller in older adults |
| Important risks | No specific safety risks reported for plant‑based protein in this metabolic study context | No specific safety risks reported for whey protein in this metabolic study context |
| Key limitations | Short‑term metabolic responses may not predict long‑term muscle outcomes; crossover feeding model may not reflect free‑living dietary habits | Same limitation applies: short‑term metabolic outcomes may not translate to habitual protein intake effects |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) lasting approximately 3 hours
Duration - 4 study days
Participants receive different protein supplements or placebo in a randomized crossover design. Each treatment day involves sip feeding of a liquid nutritional supplement every 20 minutes for 5 hours with baseline and tracer blood sampling to assess metabolic responses.
4 visits (in-person), one for each supplement administration
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
8
Have more questions? Get in touch with our team for quick support
V N Hüttl, Nep Deutz, R A Wierzchowska-McNew...
https://pubmed.ncbi.nlm.nih.gov/42149813/Texas A&M University
Lead Sponsor